Delivery Order SPE2DB20D2014-SPE2DB24FC37A

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $1,699.17 firm fixed price contract is for the supply of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen holds as the primary vehicle to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,961.48 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00, which serves...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,631.55 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through July 3, 2024, is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a respiratory medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,810.44 delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order worth $9,144.38 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with a period of performance through July 5, 2024. This Delivery Order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999 through December 2025. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $13,086.62 and a completion date of August 20, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,547.51 firm-fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a performance period through May 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,504.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical product. It has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,119.81 to AmerisourceBergen Drug Corp, Corporate Office Division, for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. This contract has no set-aside designation and has an ultimate completion date of September 19, 2024. AmerisourceBergen is a leading pharmaceutical distributor that provides a wide range of essential medical commodities, including prescription medications, vaccines,...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC37A
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $2,128.13 for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products.

Generated 9/30/24, 3:44 PM